Supporting primary care in diagnosis and choice of treatment for patients with psychosocial symptoms: SGE-PsyScan.

Supporting primary care in diagnosis and choice of treatment for patients with psychosocial symptoms: SGE-PsyScan. - SGE-PsyScan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON38647

Enrollment

648

Registered

2013-09-18

Start date

2013-12-04

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental disorders

Interventions

The SGE-PsyScan is an internet application to which the GP refers the patient which includes the distress screener, the 4-Dimensional Symptom Questionnaire (4DSQ) and a series of additional question

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with (suspected) psychosocial symptoms Aged 18 years or older and capacitated Adequate understanding of Dutch language Able to perform SGE-PsyScan at home, individually

Exclusion criteria

Exclusion criteria: Clear and treatable somatic causes of symptoms Acute distress/danger No written informed consent

Design outcomes

Primary

Measure	Time frame
The rate of patients who achieve a successful decrease in the level of psychosocial symptoms as measured with the Symptom Checklist 90 (SCL-90) after 12 months. A successful treatment result is defined as a decrease in the SCL-90 patient score of 50%.	—

Secondary

Measure	Time frame
1. The level of psychosocial symptoms of patients as measured with the SCL-90 after 3 and 6 months. 2. Health technology assessment. We will measure direct and indirect costs in both groups in order to perform a cost effectiveness analysis. Therefore we will use the Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) and EMR parameters indicating relevant expenditures including treatments, consultations and referrals 3. Quality of life will be measured using the EuroQol-5Dimensions-5Levels (EQ-5D-5L) questionnaire 4. The extent of patient satisfaction with the care they receive, will be measured using the Patient Assessment of Chronic Illness Care (PACIC) 5. Relevant psychosocial care parameters will be extracted from the EMR to monitor changes in care patterns including previous psychosocial episodes, numbers and types of psychosocial diagnoses, use of screening/diagnostic instruments, comorbidity, treatments, medication prescriptions, referrals and health care consumption. 6. Patient characteristics including gender, age, civil state, postal area code (4 numbers), education, work and comorbidity will be assessed using the TiC-P and the EMR. We will administer the Assessment of Chronic Illness Care (ACIC) to the GPs who participated in the study.	—

Measure

Time frame

1. The level of psychosocial symptoms of patients as measured with the SCL-90 after 3 and 6 months. 2. Health technology assessment. We will measure direct and indirect costs in both groups in order to perform a cost effectiveness analysis. Therefore we will use the Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) and EMR parameters indicating relevant expenditures including treatments, consultations and referrals 3. Quality of life will be measured using the EuroQol-5Dimensions-5Levels (EQ-5D-5L) questionnaire 4. The extent of patient satisfaction with the care they receive, will be measured using the Patient Assessment of Chronic Illness Care (PACIC) 5. Relevant psychosocial care parameters will be extracted from the EMR to monitor changes in care patterns including previous psychosocial episodes, numbers and types of psychosocial diagnoses, use of screening/diagnostic instruments, comorbidity, treatments, medication prescriptions, referrals and health care consumption. 6. Patient characteristics including gender, age, civil state, postal area code (4 numbers), education, work and comorbidity will be assessed using the TiC-P and the EMR. We will administer the Assessment of Chronic Illness Care (ACIC) to the GPs who participated in the study.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)